Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Genitourinary 2CNS 2Other solid neoplasm 1Gastrointestinal 1

Conditions

Leukemia 103Leukemia, Myeloid, Acute 93Myelodysplastic Syndromes 84Lymphoma 71Precursor Cell Lymphoblastic Leukemia-Lymphoma 65Lymphoma, Non-Hodgkin 58Multiple Myeloma 57Hodgkin Disease 52Leukemia, Lymphocytic, Chronic, B-Cell 49Congenital Abnormalities 46Leukemia, Myeloid, Chronic-Phase 42Lymphoma, Large B-Cell, Diffuse 40Neoplasms, Plasma Cell 39Lymphoma, Follicular 39Myeloproliferative Disorders 38Leukemia, Myelomonocytic, Chronic 37Leukemia, Myeloid, Accelerated Phase 37Lymphoma, Mantle-Cell 35Lymphoma, Large-Cell, Immunoblastic 33Lymphoma, B-Cell, Marginal Zone 33Burkitt Lymphoma 33Blast Crisis 32Anemia, Refractory, with Excess of Blasts 31Primary Myelofibrosis 28Recurrence 23Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 23Leukemia, Myelogenous, Chronic, BCR-ABL Positive 23Dendritic Cell Sarcoma, Interdigitating 23Myelodysplastic-Myeloproliferative Diseases 22Lymphoma, T-Cell, Cutaneous 20

Interventions

Temozolomide 94Radiotherapy 59Bevacizumab 59Radiosurgery 41Carboplatin 27Irinotecan 26Magnetic Resonance Spectroscopy 25Surgical Procedures, Operative 23Etoposide 22Carmustine 20Filgrastim 18Erlotinib Hydrochloride 17Cyclophosphamide 16Cisplatin 16Vincristine 15Lomustine 15Lapatinib 15Sorafenib 13Radiation 13Trastuzumab 12Nivolumab 12Imatinib Mesylate 12Thalidomide 11Surveys and Questionnaires 11Granulocyte Colony-Stimulating Factor 11Radiotherapy, Intensity-Modulated 10Aminolevulinic Acid 10temsirolimus 9Topotecan 9Thiotepa 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Brain Neoplasms × Busulfan × Clear all
NCT00638898 2025-03-20

Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor

City of Hope Medical Center

Phase 1 Completed
25 enrolled
CNSGenitourinarySarcoma

Familial ependymoma, Astrocytoma, Brain Neoplasms, Medulloblastoma, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Testicular Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Optic Nerve Glioma

NCT01505569 2024-02-26

Auto Transplant for High Risk or Relapsed Solid or CNS Tumors

Masonic Cancer Center, University of Minnesota

Phase NA Completed
44 enrolled
CNSGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Brain Neoplasms, Carcinoma, Renal Cell, Medulloblastoma, Neoplasms, Germ Cell and Embryonal, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Central Nervous System Neoplasms, Hepatoblastoma, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡